🇸🇬 Reyvow in Singapore

Reyvow (LASMIDITAN) regulatory status in Singapore.

Marketing authorisation

HSA

  • Status: likely_approved

Reyvow in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in Singapore

Frequently asked questions

Is Reyvow approved in Singapore?

Yes. HSA has authorised it.

Who is the marketing authorisation holder for Reyvow in Singapore?

Eli Lilly is the originator. The local marketing authorisation holder may differ — check the official source linked above.